[en] OBJECTIVE: To describe outcome of treatment with propofol and phenobarbital for status epilepticus (SE) after portosystemic shunt (PSS) attenuation. CASE OR SERIES SUMMARY: Three dogs without preceding seizure activity, were diagnosed with a single extrahepatic PSS. Following standard preoperative medical therapy, an ameroid constrictor was placed surgically. Recovery was uneventful until spontaneous SE developed 46-96 hours after surgery. After unsuccessful seizure control with benzodiazepines, dogs were treated with a bolus of propofol followed by a propofol constant rate infusion. Phenobarbital was concurrently administered and supportive care was optimized. All dogs recovered uneventfully over the next 7-9 days. Over the following months phenobarbital was slowly tapered. All dogs have been free from antiepileptic drugs for several months, without recurrence of neurologic signs. NEW OR UNIQUE INFORMATION PROVIDED: In this case series, we describe the treatment of 3 dogs with propofol and phenobarbital for refractory SE following attenuation of a single congenital PSS. After weaning of the propofol constant rate infusion, and tapering and discontinuation of phenobarbital over the following months, all dogs experienced a complete recovery. This study provides evidence that use of propofol in combination with phenobarbital may be efficacious for management of SE in dogs after PSS surgery.
Disciplines :
Veterinary medicine & animal health
Author, co-author :
Gommeren, Kris ; Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Unité des Soins Intensifs
Claeys, Stéphanie ; Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Chirurgie des Animaux de Compagnie
de Rooster, Hilde; Universiteit Gent - Ugent
Hamaide, Annick ; Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Chirurgie des Animaux de Compagnie
Daminet, Sylvie; Universiteit Gent - Ugent
Language :
English
Title :
Outcome from status epilepticus after portosystemic shunt attenuation in 3 dogs treated with propofol and phenobarbital
Richter KP. Diseases of the liver and hepatobiliary system. Handbook of Small Animal Gastroenterology 2003, 330-334. Tams TR. In, eds, St Louis, Saunders, pp
Watson PJ, Herrtage ME. Medical management of congenital portosystemic shunts in 27 dogs - a retrospective study. J Small Anim Pract 1998, 39((2)):62-68.
Mehl M. Portosystemic shunt management. Small Animal Critical Care Medicine 2009, 634-637. Silverstein DCHopper K. In, eds, 1st edn, St Louis, Saunders Elsevier, pp
Hardie EM, Kornegay JN, Cullen JM. Status epilepticus after ligation of portosystemic shunts. Vet Surg 1990, 19((6)):412-417.
Tisdall PL, Hunt GB, Youmans KR. Neurological dysfunction in dogs following attenuation of congenital extrahepatic portosystemic shunts. J Small Anim Pract 2000, 41((12)):539-546.
Mathews K, Gofton N. Congenital extrahepatic portosystemic shunt occlusion in the dog: gross observations during surgical correction. J Am Anim Hosp Assoc 1988, 24((4)):387-394.
Heldmann E, Holt DE, Brockman DJ. Use of propofol to manage seizure activity after surgical treatment of portosystemic shunts. J Small Anim Pract 1999, 40((12)):590-594.
Matushek KJ, Bjorling D, Mathews K. Generalized motor seizures after portosystemic shunt ligation in dogs: five cases (1981-1988). J Am Vet Med Assoc 1990, 196((12)):2014-2017.
Yool DA, Kirby BM. Neurological dysfunction in three dogs and one cat following attenuation of intrahepatic portosystemic shunts. J Small Anim Pract 2002, 43((4)):171-176.
Steffen F, Grasmueck S. Propofol for treatment of refractory seizures in dogs and a cat with intracranial disorders. J Small Anim Pract 2000, 41((11)):496-499.
Quesnel AD. Seizures. Textbook of Veterinary Internal Medicine 2005, 164-170. Ettinger SJFeldman EC. In, eds, 6th ed, St Louis, Elsevier Saunders, pp
Mehl ML, Kyles AE, Hardie EM. Evaluation of ameroid ring constrictors for treatment for single extrahepatic portosystemic shunts in dogs: 168 cases (1995-2001). J Am Vet Med Assoc 2005, 226((12)):2020-2030.
Aronson LR, Gacad RC, Kaminsky-Russ K. Endogenous benzodiazepine activity in the peripheral and portal blood of dogs with congenital portosystemic shunts. Vet Surg 1997, 26((3)):189-194.
Batshaw ML, Robinson MB, Hyland K. Quinolinic acid in children with congenital hyperammonemia. Ann Neurol 1993, 34((5)):676-681.
Maddison JE. Hepatic encephalopathy. Current concepts of the pathogenesis. J Vet Intern Med 1992, 6((6)):341-353.
Holt DE, Washabau RJ, Djali S. Cerebrospinal fluid glutamine, tryptophan, and tryptophan metabolite concentrations in dogs with portosystemic shunts. Am J Vet Res 2002, 63((8)):1167-1171.
Kyles AE, Hardie EM, Mehl M. Evaluation of ameroid ring constrictors for the management of single extrahepatic portosystemic shunts in cats: 23 cases (1996-2001). J Am Vet Med Assoc 2002, 220((9)):1341-1347.
Swalec TKM, Seguin B, Johnston G. Surgical approaches to single extrahepatic portosystemic shunts. Compend Contin Educ Pract Vet 1998, 20:593-601.
Besancon MF. al. E. Evaluation of the characteristics of venous occlusion after placement of an ameroid constrictor. In: Proceedings of the 13th Annual ACVS Symposium; 2003: Washington, DC. p. 3
Vogt JC, Krahwinkel DJ, Bright RM. Gradual occlusion of extrahepatic portosystemic shunts in dogs and cats using the ameroid constrictor. Vet Surg 1996, 25((6)):495-502.
Kummeling A, Van Sluijs FJ, Rothuizen J. Prognostic implications of the degree of shunt narrowing and of the portal vein diameter in dogs with congenital portosystemic shunts. Vet Surg 2004, 33((1)):17-24.
Hunt GB, Kummeling A, Tisdall PL. Outcomes of cellophane banding for congenital portosystemic shunts in 106 dogs and 5 cats. Vet Surg 2004, 33((1)):25-31.
Mayer SA, Claassen J, Lokin J. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002, 59((2)):205-210.
Treiman DM, Meyers PD, Walton NY. A comparison of four treatments for generalized convulsive status epilepticus. Veterans affairs status epilepticus cooperative study group. N Engl J Med 1998, 339((12)):792-798.
Peduto VA, Concas A, Santoro G. Biochemical and electrophysiologic evidence that propofol enhances GABAergic transmission in the rat brain. Anesthesiology 1991, 75((6)):1000-1009.
Stecker MM, Kramer TH, Raps EC. Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia 1998, 39((1)):18-26.
Sebel PS, Lowdon JD. Propofol: a new intravenous anesthetic. Anesthesiology 1989, 71((2)):260-277.
Baumeister FA, Oberhoffer R, Liebhaber GM. Fatal propofol infusion syndrome in association with ketogenic diet. Neuropediatrics 2004, 35((4)):250-252.
Niermeijer JM, Uiterwaal CS, Van Donselaar CA. Propofol in status epilepticus: little evidence, many dangers? J Neurol 2003, 250((10)):1237-1240.
DeLorenzo RJ, Waterhouse EJ, Towne AR. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 1998, 39((8)):833-840.
Parviainen I, Uusaro A, Kalviainen R. Propofol in the treatment of refractory status epilepticus. Intensive Care Med 2006, 32((7)):1075-1079.
Abend NS, Dlugos DJ. Treatment of refractory status epilepticus: literature review and a proposed protocol. Pediatr Neurol 2008, 38((6)):377-390.
Holtkamp M, Masuhr F, Harms L. The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists. J Neurol Neurosurg Psychiatry 2003, 74((8)):1095-1099.
Claassen J, Hirsch LJ, Emerson RG. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002, 43((2)):146-153.
Waterman AE, Hashim MA. Effects of thiopentone and propofol on lower oesophageal sphincter and barrier pressure in the dog. J Small Anim Pract 1992, 33((11)):530-533.
